首页> 外国专利> LOCALIZED LIBERTACATION OF FACTORS THAT INCREASE THE SURVIVAL OF TRANSPLANTED CELLS

LOCALIZED LIBERTACATION OF FACTORS THAT INCREASE THE SURVIVAL OF TRANSPLANTED CELLS

机译:本地化解放可增加移植细胞存活率的因素

摘要

Growth factors and/or angiogenic factors are administered in combination with dissociated cells to be transplanted, preferably in microspheres with the cells on or in a polymeric matrix, to enhance survival and proliferation of the transplanted cells. Examples demonstrate that epidermal growth factor (EGF) was incorporated into microspheres fabricated from a copolymer of lactic and glycolic acid using a double emulsion technique, the incorporated EGF was steadily released over one month in vitro, and it remained biologically active, as determined by its ability to stimulate DNA synthesis, division, and long-term survival of cultured hepatocytes. EGF-containing microspheres were mixed with a suspension of hepatocytes, seeded onto porous sponges, and implanted into the mesentery of two groups of Lewis rats, to demonstrate efficacy in vivo. Two weeks after implantation in PCS animals, devices which included EGF-containing microspheres showed a two-fold increase in the number of engrafted hepatocytes, as compared to implants which received blank microspheres.
机译:生长因子和/或血管生成因子与待移植的离解细胞联合给药,优选在微球中,将细胞置于聚合基质之上或之中,以增强移植细胞的存活和增殖。实施例表明,表皮生长因子(EGF)已通过双乳化技术掺入由乳酸和乙醇酸共聚物制成的微球中,掺入的EGF在体外稳定释放一个月以上,并保持生物活性,这取决于其刺激培养的肝细胞的DNA合成,分裂和长期存活的能力。将含EGF的微球与肝细胞悬液混合,接种到多孔海绵上,然后植入两组Lewis大鼠的肠系膜中,以证明其体内功效。植入PCS动物后两周,与包含空白微球的植入物相比,包含含EGF的微球的装置显示出植入的肝细胞数量增加了两倍。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号